IASLC podcasts

Welcome to the IASLC's "Latest in Lung Cancer Research" podcast series:

Episode 1: EGFR Inhibitors as First-Line Therapy In Advanced Non-Small Cell Lung Cancer
Spokesperson: Dr. Ramaswamy Govindan
Host: Dr. Roy Herbst
http://www.healthnewscasts.com/cancer/lung-cancer/iaslc
Dr. Roy Herbst, professor of thoracic medical oncology at the University of Texas M.D. Anderson Cancer Center and member of the IASLC speaks with Dr. Ramaswamy Govindan, an associate professor of medical oncology at the Washington University School of Medicine in St. Louis about the latest research in using targeted therapies in treating non-small cell lung cancer.

Episode 2: IASLC Staging Initiative and What It Means For Lung Cancer Diagnosis and Treatment
Spokesperson: Dr. Peter Goldstraw
Host: Dr. David Gandara
http://www.healthnewscasts.com/cancer/lung-cancer/iaslc
Dr. David Gandara, director of the thoracic oncology program at University of California Davis Cancer Center and President-Elect of the IASLC is joined by Dr. Peter Goldstraw, professor of thoracic surgery at the National Heart and Lung Institute in London as they discuss the IASLC's Lung Cancer Staging Project and possible changes in the way lung cancer is diagnosed and treated.

Episode 3: Analyzing Exhaled Breath for the Diagnosis of Lung Cancer
Spokesperson: Dr. Peter Mazzone
Host: Dr. Fred Hirsch
http://www.healthnewscasts.com/cancer/lung-cancer/iaslc
Dr. Fred Hirsch, Professor of Medicine and Pathology at the University of Colorado Denver and board member of the IASLC, is joined by Dr. Peter Mazzone, Director of Education at the Cleveland Clinic's Respiratory Institute, as they discuss Dr. Mazzone's research on finding new methods of detecting and assessing risk for lung cancer by analyzing chemicals found in exhaled breath.